Refractory overactive bladder

Philip E.V. Van Kerrebroeck*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Abstract

Overactive bladder (OAB) is a prevalent health issue that affects millions of people of all ages around the world. OAB comprises a constellation of symptoms that includes urinary frequency and urgency with or without urgency incontinence and can have a tremendous impact on an individual's quality of life. The American Urological Association OAB guidelines suggests starting with first- and second-line therapies that include conservative measures (avoidance of dietary bladder irritants and physical therapy) and pharmacotherapy (antimuscarinics or beta-3 agonists), respectively. When first- and second-line therapies are ineffective in providing relief of symptoms, one can consider more advanced therapies such as neuromodulation, onabotulinum toxin A injection of the bladder, and surgical reconstruction of the lower urinary tract. This chapter provides a case-based illustration of the approach to OAB.
Original languageEnglish
Title of host publicationFemale Pelvic Medicine: Challenging Cases with Expert Commentary
PublisherSpringer International Publishing
Pages121-131
Number of pages11
ISBN (Electronic)9783030548391
ISBN (Print)9783030548384
DOIs
Publication statusPublished - 13 Apr 2021

Keywords

  • Guidelines
  • Neuromodulation
  • Onabotulinum toxin A
  • Overactive bladder
  • Third-line therapies

Fingerprint

Dive into the research topics of 'Refractory overactive bladder'. Together they form a unique fingerprint.

Cite this